PT-141 Dosage for Women: Label, Studies and Timing | telos rx
Woman sitting calmly outdoors facing warm morning sunlight through palm trees
← Back to blog
bremelanotide

PT-141 Dosage for Women: What the Research Used

By telos rx Editorial Team

The best studied PT-141 dosage for women is 1.75 mg under the skin, used as needed before sex, per the Vyleesi label. Compounded PT-141 doses are set by your provider. See how telos rx PT-141 works.

PT-141 is the research name for bremelanotide. It works on melanocortin receptors in the brain, which are tied to desire and arousal. That makes it different from drugs that act on blood flow.

When women ask about dosing, they usually want three answers. How much is used, when to take it, and how often is too often. The clearest answers come from the branded product's label and the trials behind it.

What Is the Standard PT-141 Dose for Women?

The only labeled dose comes from Vyleesi, the branded bremelanotide autoinjector. According to the Vyleesi prescribing information on DailyMed, the dose is 1.75 mg injected under the skin of the abdomen or thigh.

The label covers premenopausal women with acquired, generalized hypoactive sexual desire disorder, often called HSDD. That means low desire that causes distress and is not explained by another condition, a relationship problem or a medication.

Compounded PT-141 is a different product. It is not FDA-approved, and it is not the same as Vyleesi. Your provider uses the label and research as a reference, then sets your dose and form.

What Doses Did Clinical Trials Test?

Two sets of trials shaped what we know. A dose finding study came first, then larger phase 3 trials.

Study Doses tested Key takeaway
Phase 2b dose finding trial 0.75 mg, 1.25 mg, 1.75 mg, or placebo The two higher doses were pooled for the main analysis.
RECONNECT phase 3 trials 1.75 mg as needed, or placebo Desire scores rose and distress fell compared with placebo.
Vyleesi label 1.75 mg as needed Sets limits on how often doses can be used.

The dose finding trial enrolled premenopausal women with female sexual dysfunction. Women self-injected as desired over 12 weeks. The most common side effects were nausea, flushing and headache.

The RECONNECT phase 3 trials included more than 1,200 women. Both trials used 1.75 mg as needed. Women on bremelanotide reported more nausea, flushing and headache than those on placebo.

These results describe group averages in a study setting. Your own response may be different.

When to Use PT-141 Before Intimacy

The Vyleesi label says to inject at least 45 minutes before expected sexual activity. It also notes that the best window has not been fully worked out. Some women find a longer lead time suits them better.

Compounded PT-141 is also used as needed. Your provider tells you how far ahead to use it. For more on timing, read how long PT-141 takes to work and our guide to PT-141 half-life.

Talk to a provider about PT-141

Complete a private online intake. A licensed provider reviews it and sets your dose and timing, subject to medical approval by a licensed provider.

Explore PT-141

How Often Can Women Use PT-141?

Frequency limits are an important part of dosing. The Vyleesi label sets two clear rules:

  • No more than one dose in 24 hours.
  • More than 8 doses per month is not recommended.

These limits relate partly to blood pressure and skin darkening, which can build with repeated use. Your provider sets your own limits for compounded PT-141. Do not add extra doses if one does not seem to work.

Does PT-141 Dosage Differ for Postmenopausal Women?

The Vyleesi label covers premenopausal women only. The label states that safety and effectiveness have not been established in postmenopausal women.

Some providers prescribe compounded PT-141 off-label for women after menopause. In that case, the provider decides whether it fits and what dose to use. Cardiovascular risk usually gets extra attention, since it tends to rise with age.

For a broader overview, see our guide to PT-141 for women and HSDD.

How PT-141 Dosing for Women Compares With Men

Most published PT-141 research in women used the 1.75 mg dose. Research in men is a separate body of work, and the Vyleesi label does not cover men. Men who use compounded PT-141 do so off-label.

If you want the male side of the picture, read PT-141 dosage for men. The names can be confusing too, so our explainer on bremelanotide vs Vyleesi vs compounded PT-141 may help.

Side Effects and Safety Limits

Nausea is the most common side effect in the trials. It tends to be strongest with the first doses. Flushing, headache and injection site reactions are also common.

A few safety points shape who should use PT-141 at all:

  1. Blood pressure. The label notes a temporary rise in blood pressure after each dose. People with uncontrolled high blood pressure or known heart disease should not use it.
  2. Skin darkening. Some women develop dark patches on the face, gums or breasts, especially with frequent use.
  3. Naltrexone. The label advises avoiding use with oral naltrexone products.
  4. Other oral medicines. Bremelanotide may slow stomach emptying, which can affect how some pills absorb.
  5. Pregnancy. Tell your provider if you are pregnant, could be pregnant or are trying.

Questions to Ask Your Provider About PT-141 Dosing

A good plan starts with good questions. Consider raising these in your intake or in a follow-up message:

  • What dose are you starting me on, and why?
  • How far ahead of intimacy should I use it?
  • How many doses per month is safe for me?
  • What should I do if nausea or flushing bothers me?
  • Do any of my current medications or supplements interact with it?
  • Should I check my blood pressure at home?

Write down how you feel after each use. Note timing, side effects and whether it helped. That record makes it easier for your provider to fine tune the plan.

How telos rx Sets Your PT-141 Plan

telos rx is an online-first, asynchronous telehealth service. You complete an intake when it suits you. A licensed provider reviews your history, blood pressure, medications and goals.

If PT-141 fits, your provider sets the dose and gives timing guidance. Your PT-141 ships ready to inject from a licensed US pharmacy, so there is no mixing or measuring powder. You can message the care team as questions come up.

Current PT-141 pricing is shown on the product page. Approval is not guaranteed, and individual results vary.

See if PT-141 fits your goals

A licensed provider reviews your intake online, on your schedule. Any prescription is subject to medical approval by a licensed provider.

Start with PT-141

Frequently Asked Questions

What is the usual PT-141 dosage for women?

The labeled dose for Vyleesi, the branded bremelanotide product, is 1.75 mg injected under the skin as needed. That dose was used in the RECONNECT phase 3 trials. Compounded PT-141 is not the same product, so a licensed provider sets your dose and form after reviewing your health history.

How long before sex should a woman take PT-141?

The Vyleesi label says to inject at least 45 minutes before anticipated sexual activity. It also notes that the best timing window has not been fully defined, so some women prefer a longer lead time. Your provider gives you timing guidance that fits your plan and your response.

How many times a month can I use PT-141?

The Vyleesi label says not to use more than one dose within 24 hours and that more than 8 doses per month is not recommended. These limits relate to blood pressure and skin darkening. Your provider sets the limits for your compounded PT-141 plan.

Can postmenopausal women use PT-141?

The Vyleesi label covers premenopausal women, and safety and effectiveness have not been established after menopause. Some providers prescribe compounded PT-141 off-label for postmenopausal women. A licensed provider weighs your cardiovascular health and other factors before deciding whether it fits.

Can I take a higher PT-141 dose if it does not work?

Do not raise your dose on your own. Higher doses tend to bring more nausea and flushing and may raise blood pressure further. If you feel PT-141 is not helping, message your provider. They can review timing, dose and whether another approach makes more sense.

Is compounded PT-141 the same as Vyleesi?

No. Vyleesi is a branded bremelanotide autoinjector with an FDA label. Compounded PT-141 contains bremelanotide but is prepared by a licensed pharmacy for an individual prescription and is not FDA-approved. Your provider explains the differences and decides which option fits you.

telos rx is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service.

Ready to see if it fits? Start your private evaluation with telos rx.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX